Clincosm LogoSign in Get a demo

Neoplasm Malignant

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Tumor Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer Trial in United States (XL102, Fulvestrant,

Recruiting
  • Neoplasm Malignant
  • +4 more
  • Atlanta, Georgia
  • +4 more
Apr 19, 2022

Tumor Malignant Trial in Worldwide (SAR245408, SAR245409)

Completed
Has Results
  • Neoplasm Malignant
  • Birmingham, Alabama
  • +20 more
Mar 30, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Tumor Malignant Trial in San Antonio (PSB205)

Recruiting
  • Neoplasm Malignant
  • PSB205
  • San Antonio, Texas
    Next Oncology
Nov 23, 2020

Tumor Malignant Trial in France, Spain, United States (SAR566658)

Completed
  • Neoplasm Malignant
  • Cincinnati, Ohio
  • +4 more
May 9, 2017

Tumor Malignant Trial in United States (Cabazitaxel (XRP6258))

Completed
  • Neoplasm Malignant
  • Cabazitaxel (XRP6258)
  • La Jolla, California
  • +13 more
Jul 20, 2015

Tumor Malignant Trial in United States (Iniparib (SAR240550-BSI-201), Gemcitabine, Carboplatin)

Completed
  • Neoplasm Malignant
  • Iniparib (SAR240550-BSI-201)
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Oct 21, 2014

Tumor Malignant Trial in Belgium, United States (SAR302503 (TG101348), Placebo SAR302503, Panolosetron)

Completed
  • Neoplasm Malignant
  • SAR302503 (TG101348)
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 3, 2014